Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Sufenta Preservative Free

(Sufentanil Citrate Injection)

LLeaf Vertical Inc.

0

Indications

1

Total Trials

1

Active Trials

0

Competitors

2

FDA Applications

NDA/BLA/ANDA regulatory filings

Timeline

Expected Milestones

Q2 2027

PreclinicalNot yet recruiting

Post Operative Pain

NCT07810413

Clinical

Trials by Indication[1]

Post Operative Pain1 trial

Anrikefon Injection for Postoperative Analgesia in Thoracoscopic Lung Surgery: A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Single-Center Clinical Study

Not yet recruiting·TThe First People's Hospital of Lianyungang·Preclinical·NCT07810413·88 enrolled

Regulatory

FDA Approval Timeline[3]

May 4, 1984

SUFENTA PRESERVATIVE FREE

NDA NDA019050

Nov 2, 2018

DSUVIA

NDA NDA209128

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Sufentanil Citrate Injection. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Sufentanil Citrate Injection compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
OpenFDA — FDA approval records (NDA NDA209128). U.S. Food & Drug Administration.
[4]
SEC EDGAR — Leaf Vertical Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Company: LLeaf Vertical Inc.

Related News